International Flavors & Fragrances is the largest specialty ingredients producer globally... Show more
In recent weeks, International Flavors & Fragrances (IFF) shares have navigated modest volatility, trading primarily in the low-to-mid $70 range within a 52-week spectrum of $59 to $84. The stock has underperformed slightly amid broader market caution, down around 3% over the past month, as investors position ahead of Q1 results. Steady dividend payouts provide a supportive yield of approximately 2.3%, while a Buy consensus from analysts reflects optimism on long-term fundamentals in the flavors and fragrances sector. Year-to-date gains hover near 6%, trailing the S&P 500 but showing resilience in consumer staples exposure.
Tickeron offers hundreds of AI Trading Bots—351 in total—that autonomously trade thousands of different tickers across diverse strategies, timeframes, and market conditions. The curated Trending AI Robots section highlights the top 25 performers, selected by advanced AI analysis for their suitability to current volatility and sector dynamics. These bots showcase impressive stats: annualized returns ranging from +23% to +163%, win rates of 51% to 88%, profit factors up to 11.7, and profit-to-drawdown ratios as high as 17. Strategies vary from short-term 5-minute scalps to 49-day swings, employing technical analysis (TA), fundamental analysis (FA), and risk-managed exits like 3% take-profit/2% stop-loss corridors. Examples include multi-agent bots targeting semiconductors or industrials with 63-75% win rates. While not specific to IFF, these tools adapt to stocks like it in consumer and materials sectors. Investors may explore Trending AI Robots for pattern-based insights amid earnings season.
International Flavors & Fragrances (IFF) has seen measured price movements in recent trading sessions, influenced by corporate updates, analyst revisions, and earnings buildup. On April 29, the company announced a $0.40 per share quarterly dividend for Q2 2026, payable July 10 to shareholders of record June 18, maintaining its shareholder-friendly stance amid market uncertainty. This followed a similar Q1 payout earlier in the quarter, reinforcing a 2.3% yield that provided downside support.
Analyst activity shaped sentiment: Barclays cut its price target to $80 from $91 on April 14, while Oppenheimer adjusted to $88 from $97 on April 22 but retained an Outperform rating; Bank of America issued a Buy reaffirmation around April 21. These tweaks, citing refined models post-Q4 results, contributed to a share pullback from mid-April highs near $75 to around $70 by late April, a roughly 6% dip aligned with a noted sell signal.
The 2026 Annual Meeting of Shareholders, held recently, saw directors elected, PwC ratified as auditors, and say-on-pay approved, signaling governance stability with minimal market impact. On April 14, IFF previewed its Q1 2026 results release for May 5, heightening focus. Analysts project $2.65 billion in revenue—a 6.7% year-over-year drop—and EPS around $1.10, potentially pressuring shares if guidance disappoints, though a beat is anticipated based on historical Zacks metrics.
Product innovation lingered in the background, with late-March pet probiotic PureStrong™ launch and participation in In-Cosmetics Global 2026 underscoring R&D momentum in health and wellness segments. Broader industry tailwinds, like demand for natural flavors, offered counterbalance, but macroeconomic pressures on consumer spending weighed. Overall, these events fostered cautious trading, with volume steady around 1.4 million shares daily, positioning IFF for potential volatility post-earnings.
As International Flavors & Fragrances (IFF) progresses through 2026, investors should track execution against full-year guidance of $10.5-10.8 billion in sales (1-4% growth) and $2.05-2.15 billion adjusted EBITDA (3-8% growth), emphasizing volume-led recovery and margin expansion. Portfolio optimization remains central, including potential divestitures like the planned Food Ingredients unit to streamline focus on high-growth Taste and Scent segments.
Opportunities lie in innovation, such as Tastepoint's 2026 flavor trends featuring nostalgia-driven profiles like cherry and chai spice, alongside biotech advances in natural ingredients amid clean-label demand. Rising fine fragrance growth (projected 31% YoY) and probiotics expansion could bolster revenue. Risks include raw material cost inflation, softening consumer demand in staples, and integration challenges from prior deals like Nutrition & Biosciences.
Competitive positioning in a market favoring sustainability, regulatory shifts on biotech, and macroeconomic factors like interest rates will be pivotal. Cash flow improvements and leverage reduction to ~2.5x support strategic flexibility.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IFF advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day moving average for IFF crossed bullishly above the 50-day moving average on May 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 224 cases where IFF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for IFF moved out of overbought territory on May 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where IFF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IFF as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IFF turned negative on June 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
IFF moved below its 50-day moving average on June 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
IFF broke above its upper Bollinger Band on May 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.324) is normal, around the industry mean (7.450). P/E Ratio (22.675) is within average values for comparable stocks, (43.494). Projected Growth (PEG Ratio) (0.843) is also within normal values, averaging (2.239). Dividend Yield (0.022) settles around the average of (0.021) among similar stocks. P/S Ratio (1.740) is also within normal values, averaging (183.803).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IFF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of flavor and fragrance products
Industry ChemicalsSpecialty